Immuron Current Deferred Revenue from 2010 to 2026

IMRN Stock  USD 0.75  0.06  7.41%   
Immuron Current Deferred Revenue yearly trend continues to be very stable with very little volatility. Current Deferred Revenue is likely to grow to about 1.7 M this year. Current Deferred Revenue is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. View All Fundamentals
 
Current Deferred Revenue  
First Reported
2001-06-30
Previous Quarter
145.7 K
Current Value
1.4 M
Quarterly Volatility
1.3 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Immuron financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immuron's main balance sheet or income statement drivers, such as Depreciation And Amortization of 75.8 K, Interest Expense of 6.2 K or Total Revenue of 8.8 M, as well as many indicators such as Price To Sales Ratio of 1.65, Dividend Yield of 0.0 or PTB Ratio of 1.91. Immuron financial statements analysis is a perfect complement when working with Immuron Valuation or Volatility modules.
  
Build AI portfolio with Immuron Stock
Check out the analysis of Immuron Correlation against competitors.
Evaluating Immuron's Current Deferred Revenue across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Immuron Ltd ADR's fundamental strength.

Latest Immuron's Current Deferred Revenue Growth Pattern

Below is the plot of the Current Deferred Revenue of Immuron Ltd ADR over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Immuron's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immuron's overall financial position and show how it may be relating to other accounts over time.
Current Deferred Revenue10 Years Trend
Slightly volatile
   Current Deferred Revenue   
       Timeline  

Immuron Current Deferred Revenue Regression Statistics

Arithmetic Mean(314,488)
Coefficient Of Variation(555.78)
Mean Deviation1,429,616
Median(1.00)
Standard Deviation1,747,863
Sample Variance3.1T
Range6.3M
R-Value0.94
Mean Square Error406.2B
R-Squared0.88
Slope323,838
Total Sum of Squares48.9T

Immuron Current Deferred Revenue History

20261.7 M
20251.7 M
20231.4 M
2021698.2 K
2020974 K
2017 -1.0
201619.1 K

About Immuron Financial Statements

Immuron investors utilize fundamental indicators, such as Current Deferred Revenue, to predict how Immuron Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.7 M1.7 M

Pair Trading with Immuron

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immuron position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immuron will appreciate offsetting losses from the drop in the long position's value.

Moving together with Immuron Stock

  0.68DWTX Dogwood TherapeuticsPairCorr
  0.7EDIT Editas MedicinePairCorr

Moving against Immuron Stock

  0.9IMMP Immutep Ltd ADRPairCorr
  0.63DSGN Design TherapeuticsPairCorr
  0.62ENGN enGene Holdings CommonPairCorr
  0.6KYTX Kyverna TherapeuticsPairCorr
  0.4263E ONWARD MEDICAL BVPairCorr
The ability to find closely correlated positions to Immuron could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immuron when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immuron - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immuron Ltd ADR to buy it.
The correlation of Immuron is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immuron moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immuron Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immuron can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Immuron Ltd ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immuron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immuron Ltd Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immuron Ltd Adr Stock:
Check out the analysis of Immuron Correlation against competitors.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Will Biotechnology sector continue expanding? Could Immuron diversify its offerings? Factors like these will boost the valuation of Immuron. Market participants price Immuron higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Immuron data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.64)
Revenue Per Share
1.28
Quarterly Revenue Growth
0.293
Return On Assets
(0.26)
Return On Equity
(0.50)
Understanding Immuron Ltd ADR requires distinguishing between market price and book value, where the latter reflects Immuron's accounting equity. The concept of intrinsic value - what Immuron's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Immuron's price substantially above or below its fundamental value.
Please note, there is a significant difference between Immuron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immuron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Immuron's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.